Changes in function of voltage-gated sodium channels in nociceptive primary sensory neurons participate in the development of peripheral hyperexcitability that occurs in neuropathic and inflammatory chronic pain conditions. Among them, the tetrodotoxin-resistant (TTX-R) sodium channel Na v 1.8, primarily expressed by small-and medium-sized dorsal root ganglion (DRG) neurons, substantially contributes to the upstroke of action potential in these neurons. Compelling evidence also revealed that the chemokine CCL2 plays a critical role in chronic pain facilitation via its binding to CCR2 receptors. In this study, we therefore investigated the effects of CCL2 on the density and kinetic properties of TTX-R Na v 1.8 currents in acutely small/medium dissociated lumbar DRG neurons from naive adult rats. Whole-cell patch-clamp recordings demonstrated that CCL2 concentration-dependently increased TTX-resistant Na v 1.8 current densities in both small-and medium-diameter sensory neurons. Incubation with CCL2 also shifted the activation and steady-state inactivation curves of Na v 1. 
Introduction
In sensory primary afferent neurons, voltage-gated sodium channels (VGSCs) are thought to play a critical role in the pathogenesis of chronic pain conditions (Amir et al., 2006; Dib-Hajj et al., 2010) . Changes in the expression, trafficking, and function of VGSC have been particularly discussed to explain the neuronal hyperexcitability observed in the painful phenotype associated with nerve injury or peripheral inflammation (Docherty and Farmer, 2009; Swanwick et al., 2010) . Several lines of evidence suggest that the tetrodotoxin-resistant (TTX-R) sodium channel Na v 1.8 mostly contributes to the enhanced excitability and spontaneous ectopic discharges occurring in small-and medium-sized dorsal root ganglion (DRG) neurons (Devor, 2006; Cummins et al., 2007; Dib-Hajj et al., 2009a) . The enhanced responsiveness of these Na v 1.8-positive neurons thus leads to the development of hyperalgesia, allodynia, and ongoing spontaneous pain (Dib-Hajj et al., 2010; Lampert et al., 2010) .
To date, several inflammatory mediators acting through G-protein-coupled receptors (GPCRs), including PGE 2 , adenosine, and serotonin, have been shown to sensitize Na v 1.8 sodium channels and therefore to significantly increase the excitability of the nociceptor (Priest, 2009; Lampert et al., 2010) . In addition to their well established role in the immune system, chemokines were also recently described to orchestrate the cellular response during the initiation/maintenance of chronic pain (Rittner and Brack, 2006; White et al., 2009; Gao and Ji, 2010) . Among them, the chemokine CCL2 was shown to play a key role in spinal nociceptive processing, notably by sensitizing primary afferent neurons White et al., 2009; White and Miller, 2010; Rostène et al., 2011) . Acting via the binding to its cognate GPCR CCR2, intrathecal delivery of exogenous CCL2 was found to promote pain hypersensitivity (Tanaka et al., 2004; Dansereau et al., 2008) . Accordingly, CCL2-overexpressing or CCR2-deficient mice exhibited altered nociceptive behaviors to thermal, chemical, and mechanical stimuli (Abbadie et al., 2003; Menetski et al., 2007; Zhang et al., 2007) . In addition, the use of CCR2 receptor antagonists or blocking antibodies successfully inhibited nociceptive signaling (Bhangoo et al., 2007 Serrano et al., 2010; Struthers and Pasternak, 2010; Van Steenwinckel et al., 2011) . Similar to pain neuromodulators (Rostène et al., 2007) , CCL2 is stored in large dense core vesicles known to contain pronociceptive-related peptides [substance P and CGRP (calcitonin gene-related peptide)], is released in a calcium-dependent manner from DRG neuronal cell bodies and terminal nerve endings, and directly excites primary nociceptive neurons by autocrine/paracrine processes (Oh et al., 2001; White et al., 2005; Sun et al., 2006; Dansereau et al., 2008; Jung et al., 2008; Van Steenwinckel et al., 2011) .
Thus, the aim of the present study was to investigate whether the mechanism of CCL2-induced sensory neuron excitation might in part arise from the enhanced activation of TTX-R sodium channel Na v 1.8 currents. For this purpose, we examined the changes induced by CCL2 on the density and biophysical properties of Na v 1.8 currents in acutely dissociated small-and medium-sized DRG neurons from naive adult rats using whole-cell patch-clamp recordings. Additional electrophysiological studies were conducted to determine whether CCR2 receptor antagonist [N-[2-[[(3S,4S) 
-1-E4-(1,3-benzodioxol-5-yl)-4-hydroxycyclohexyl]-4-ethoxy-3-pyrrolidinyl] amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide (INCB3344)]
could inhibit the cross talk between CCR2 and Na v 1.8 (Brodmerkel et al., 2005) . Finally, in light of the association of CCR2 with G i/oprotein subunits (Bajetto et al., 2002) , we further evaluated the molecular basis of this functional interaction by exploring the effects of signaling inhibitors on Na v 1.8 currents evoked by CCR2 activation.
Materials and Methods
Animals. Adult male Sprague Dawley rats (250 -300 g) were housed two per cage in a climate-controlled room on a 12 h light/dark cycle with water and food ad libitum. All experimental procedures were approved by the Animal Care and Use Committee of the Université de Sherbrooke and were in accordance with the guidelines provided by the Canadian Council of Animal Care.
Acute culture of DRG neurons. DRG neurons from adult rats were acutely isolated as described previously (Zhou et al., 2003) . Briefly, rats were exposed to CO 2 and decapitated. The bilateral L4 -L5 DRGs were isolated, quickly unsheathed in calcium/magnesium-free PBS with glucose (1.6 M), and all adherent connective tissue was removed. Isolated DRGs were then enzymatically digested with collagenase A for 90 min (1 mg/ml; Roche Diagnostics) in PBS containing glucose, and then for 30 min with trypsin (0.25%) (Invitrogen). Subsequently, DRG neurons were mechanically dissociated by repeated trituration using a fine polished Pasteur pipette in culture medium containing 1:1 DMEM and Ham's F12 medium, supplemented with 10% fetal bovine serum (Invitrogen) and 1% penicillin (100 U/ml)/streptomycin (0.1 mg/ml). Isolated neurons were gently centrifuged (50 ϫ g for 3 min), plated on poly-Dlysine/laminin-coated glass coverslips, and incubated at 37°C in a humidified 95% air/5% CO 2 atmosphere. All of the electrophysiological recordings or immunocytochemical experiments were performed within 14 -20 h, a sufficient time to allow the cells to adhere to the plate. For the immunocytochemical detection, DRG neurons were fixed for 15 min with 4% paraformaldehyde (PFA) for further immunostaining. During the brief period of culture, DRG neurons displayed only short axonal processes (Ͻ10 m), thus facilitating the voltage-clamp studies, and minimizing changes in electrical properties that can occur in long-term culture.
Immunofluorescence labeling. For tissue sections, rats were deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and perfused transaortically with saline, followed by 4% PFA containing 0.8% picric acid in 0.1 M PBS. Lumbar DRGs were rapidly dissected and postfixed in the same fixative overnight at 4°C. DRGs were then cryoprotected in 30% sucrose and frozen 1 min at Ϫ40°C in isopentane. DRGs were sliced using a cryostat in 12 m (Jung CM 3100; Leica Microsystems) sections, and then mounted on Superfrost slides. To simultaneously detect CCR2 and Na v 1.8, tissue sections and cultured DRG neurons were processed for dual immunofluorescence labeling. Specimens were incubated in 0.1 M PBS containing 3% NGS and 0.1% Triton X-100 for 2 h, and then treated with a rabbit CCR2 antibody for 1 h (Gosselin et al., 2005) . After rinsing three times with 0.1 M PBS, sections were incubated with a biotinconjugated goat anti-rabbit antibody (1:1000; Vector Laboratories) for 1 h and finally revealed by incubation with streptavidin-Alexa Fluor 488 (1:1000; Invitrogen). Subsequently, cultured rat DRG neurons and L4 -L6 DRG sections were incubated with a goat anti-rabbit IgG (Vector; 1:100) for 1 h to completely block sites of primary CCR2 antibody. Specimens were then treated with rabbit anti-Na v 1.8 (1:500; Alomone Labs) and stained with Alexa Fluor 555-conjugated goat anti-rabbit (1:1000; Invitrogen). Specimens were then washed and mounted with Aquamount. We performed primary and secondary antibody control experiments for each combination of primary and secondary antibodies, to evaluate nonspecific secondary antibody binding and cross-reactivity between primary and secondary antibodies. Experiments performed in the absence of primary and/or secondary antibody revealed an absence of immunofluorescence labeling (data not shown). Double-labeled sections were analyzed by light microscopy using a Zeiss fluorescence microscope (Carl Zeiss) fitted with highly discriminating filters. Pictures were taken using a digital camera (AxioCam HRC; Carl Zeiss) connected to an image acquisition software (AxioVision; Carl Zeiss).
cAMP assay. Acutely dissociated DRG neurons were dispensed into poly-D-lysine-coated 24-well plates (2 ϫ 10 5 cells per well). After 16 h, cells were preincubated for 2 h at 37°C in 200 l of Krebs'-Ringer's solution (10 mM HEPES, 118 mM NaCl, 2.5 mM CaCl 2 , 4.75 mM KCl, 1.2 mM MgSO 4 1.2 mM KH 2 PO 4 , 24 mM NaHCO 3 , 11.1 mM glucose, and 0.3% BSA) in the presence or not of the G i inhibitor, pertussis toxin (PTX) (250 ng/ml; Sigma-Aldrich). The medium was then replaced by 200 l of Krebs'-Ringer's solution containing 0.1 mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich), a nonspecific cyclic nucleotide phosphodiesterase inhibitor, and the cells were incubated for 15 min at 37°C. Then, 200 l of a solution containing CCL2 (at a final concentration of 100 nM) were added to the medium, and the cells were incubated for another 30 min at 37°C. Basal levels were determined in parallel by incubating cells in the absence of CCL2 for 30 min at 37°C in 400 l of Krebs'-Ringer's solution containing 0.1 mM IBMX. The reaction was stopped by replacing the incubation medium with 100 l of 0.1N HCl for 20 min at room temperature. Next, the cells were scraped and centrifuged for 10 min at 10,000 rpm. Collected supernatants were then processed directly for cAMP determination by using the cAMP Direct Immunoassay kit (Abcam; ab65355), as recommended by the manufacturer.
Whole-cell patch-clamp recordings. Sodium currents were recorded from single, small-to medium-sized DRG neurons in the whole-cell patch-clamp configuration 14 -20 h after dissociation and plating, using an Axopatch 200B amplifier (Molecular Devices). All experiments were performed at room temperature (21-23°C). The intracellular recording electrodes were made from borosilicate glass capillary tubes (Warner Instruments), pulled using a two-step vertical micropipette puller P83 (Narashige), and heat-polished on a microforge (Narashige).
The pipette solution contained the following (in mM): 10 NaCl, 140 CsCl, 10 EGTA, 1 MgCl 2 , 2 Na 2 ATP, 10 HEPES; pH was adjusted to 7.2 by CsOH. Osmolarity was adjusted to 310 mOsm/L with sucrose. Pipettes had a resistance of 2-4 M⍀ when filled with the pipette solution. After formation of a tight seal (Ͼ1 G⍀), whole-cell access was obtained by rupturing the membrane, and membrane resistance and capacitance (C m ) were determined. Capacity transients were cancelled using computer-controlled circuitry and series resistance was compensated (Ͼ85%) in all experiments. The external solution contained the following (in mM): 35 NaCl, 65 NMDG-Cl, 30 tetraethylammonium (TEA)-Cl, 0.1 CaCl 2 , 0.1 CoCl 2 , 5 MgCl 2 , 10 HEPES, and 10 glucose, pH adjusted at 7.4 by NaOH and osmolarity adjusted to 300 mOsm/L. The TEA-Cl and CoCl 2 were used to inhibit endogenous K ϩ and Ca 2ϩ currents, respectively. The external sodium concentration was reduced to 35 mM to maintain adequate clamp of currents and to ensure that the particular current under study was stable. Note that the amplitude of Na ϩ currents was not affected over the time period used to record the effects of the different drugs.
Using a whole-cell configuration, TTX-R Na v 1.8 currents were isolated by prepulse inactivation as described previously (MeLean et al., 1988; Roy and Narahashi, 1992; Cummins and Waxman, 1997) . Briefly, standard current-voltage ( I-V) families were constructed using a holding potential of Ϫ120 mV with 500 ms prepulses to Ϫ50 mV before each depolarization to inactivate the fast TTX-sensitive (TTX-S) currents. Thus, standard I-V curves were obtained by the application of a series of test pulses to voltages that ranged from Ϫ70 to ϩ40 mV in 10 mV increments after the prepulse inactivation protocol (see Fig. 2 ). The voltage dependence of inactivation was measured by applying a double-pulse protocol consisting of a 500 ms conditioning potential (Ϫ120 to Ϫ10 mV, 5 mV increments) followed by a fixed test pulse (Ϫ10 mV, 50 ms). The current amplitude ( I) was normalized to the maximum control current amplitude (I max ).
Drugs. CCL2 (PeproTech) was applied at two different concentrations (10 and 100 nM) to the chamber for 30 min before patch-clamp recordings. Cultured DRG neurons were also treated with 100 nM CCL2 in the presence of increasing concentrations (1-100 nM) of the CCR2 antagonist INCB3344 (Global Pfizer; Pure Substance Program). DRG cells were also pretreated overnight with PTX (250 ng/ml) or with gallein, a specific G␤␥ dimer signaling inhibitor (20 M; Tocris Bioscience).
Data analysis and statistics. The peak inward current values at each potential were plotted to generate I-V curves. Conductance ( G) was determined as I/(V m Ϫ V rev ), where I is the current, V m is the potential at which current is evoked, and V rev is the reversal potential of the current. Activation was fitted with the following Boltzmann equation:
where V m is the test pulse voltage potential at which current is evoked, G max is the calculated maximal conductance, V 1/2 is the potential of half-activation or inactivation, and k is the slope factor. The normalized curves were fitted using a Boltzmann distribution equation as follows:
, where I max is the peak sodium current elicited after the most hyperpolarized prepulse, V m is the preconditioning pulse potential, V 1/2 is the half-maximal sodium current, and k is the slope factor. INCB3344 doseresponse curve was obtained by bracketing the responses to different INCB3344 concentrations (1-100 nM).
Recording data were acquired using a Digidata 1440 A series interface (Molecular Devices) digitized at 10 kHz, low-pass filtered at 2 kHz, and captured using pClamp software (version 10.2; Molecular Devices). For current density measurements, the currents were divided by the cell capacitance (C m ) as read from the amplifier. Cells were selected for recording based on whole-cell capacitance (C m Ͻ 30 pF corresponding to small neurons, Ͻ25 m; C m Ͻ 55 pF corresponding to medium neurons, Ͻ25-32 m). The offset potential was zeroed before patching the cells and leakage current was digitally subtracted on-line using hyperpolarizing potentials, applied after the test pulse.
Data are expressed as means Ϯ SEM. Statistical analyses were performed using Student's t test or one-way ANOVA followed by Dunnett's posttest. A value of p Ͻ 0.05 was considered statistically significant. Curves were fitted using Origin software (OriginLab Corporation), and graphs were plotted using GraphPad, version 5.d (GraphPad Software). Final composites were processed using Deneba's Canvas 10.5 imaging software (Deneba Software).
Results
Colocalization of Na v 1.8 and CCR2 in cultured rat sensory neurons and DRG tissue To determine whether Na v 1.8 was present within the same sensory neuronal population as CCR2, dual immunofluorescence labeling was performed on dissociated primary afferent neurons and on DRG sections from naive rats (Fig. 1) . Dual immunostaining revealed that Na v 1.8 and CCR2 colocalized extensively over small-to medium-sized sensory neurons ( Fig. 1 A-F ) . At higher magnification, the distribution patterns for both Na v 1.8 and CCR2 were entirely restricted to the periphery of the neuron somata (Fig. 1 D-F ) . Accordingly, fluorescence microscopy performed on DRG tissue sections revealed that numerous Na v 1.8-positive small and medium sensory neurons were also immunoreactive for CCR2 (Fig. 1G-I ). In addition, CCR2 and Na v 1.8 immunoreactivities were detected in axonal fibers in DRG sections, suggesting anterograde transport of both proteins to nerve terminals (data not shown). The presence of CCR2 receptors on Na v 1.8-positive neurons led us to investigate, by electrophysiological approaches, whether the CCR2 ligand CCL2 could modulate the TTX-resistant Na v 1.8 currents. D) and Na v 1.8 (red) (B, E) on acutely dissociated primary afferent neurons. The merged images show dually labeled small-and mediumsized sensory neurons (yellow) (C, F ). Note that CCR2 and Na v 1.8 are mainly detected at the periphery of the cell. Immunohistochemical labeling performed on DRG sections from naive rats (G-I ). Numerous small-to medium-diameter DRG neurons display both Na v 1.8 and CCR2 immunoreactivities. Scale bars, 20 m.
CCL2 enhances Na v 1.8 currents in small primary sensory neurons Several protocols exist to isolate TTX-R from TTX-S sodium currents. Here, we applied a prepulse inactivation protocol with a 500 ms step of Ϫ50 mV to isolate the slow-inactivating TTX-R sodium currents (MeLean et al., 1988; Roy and Narahashi, 1992; Cummins and Waxman, 1997) . Furthermore, the membrane potential was held at Ϫ70 mV to inhibit Na v 1.9 currents, leaving the Na v 1.8 current intact (Rush et al., 2005; Cang et al., 2009) . The family of Na v 1.8 sodium currents was generated with a voltage-clamp protocol by applying a range of potentials between Ϫ70 and ϩ40 mV for 100 ms (Fig. 2) . Using a whole-cell patch-clamp configuration, we therefore examined the effects of CCL2 on the density and kinetic properties of TTX-R Na v 1.8 currents in acutely dissociated lumbar DRG neurons. Na v 1.8 current amplitude was increased in small neurons (C-fibers) following an incubation of 30 min with 100 nM CCL2 (Fig. 2) . Under these conditions, currentvoltage ( I-V) analysis revealed that the mean peak current amplitude was significantly higher in CCL2-treated (Ϫ99.13 Ϯ 2.77 pA/pF; n ϭ 11) than in control DRG neurons (Ϫ53.30 Ϯ 2.15 pA/pF; n ϭ 13) (Fig. 3 A, B ; ***p Ͻ 0.001). The peak current density was also affected significantly at the lowest concentration of CCL2 (10 nM) (Ϫ63.55 Ϯ 12.26 pA/ pF; n ϭ 4; *p Ͻ 0.05; Fig. 3 A, B) .
Acute application of 100 nM CCL2 also shifted the activation and steady-state inactivation curves of Na v 1.8 in a hyperpolarizing direction (Fig. 3C,D) . The midpoint of activation (V 1/2act ) was significantly decreased in CCL2-treated neurons compared with control neurons (Ϫ18.74 Ϯ 0.31 mV, n ϭ 11, vs Ϫ8.45 Ϯ 0.21 mV, n ϭ 13, respectively; ***p Ͻ 0.001) (Fig. 3C, Table 1 ). The slope factor (k act ) was not affected by CCL2 perfusion (k control ϭ 4.73 Ϯ 0.19 vs k CCL2 ϭ 4.47 Ϯ 0.29 mV; Table 1 ). Similar to the activation curve, the steady-state inactivation parameter, hinf, was significantly influenced by the presence of CCL2 (Fig. 3D) . Indeed, the half-inactivation potential (V 1/2inact ) was shifted to Ϫ40.61 Ϯ 0.09 mV (n ϭ 10) from that of control condition (Ϫ30.55 Ϯ 0.17 mV; n ϭ 10) after 100 nM CCL2 treatment (***p Ͻ 0.001; Table 1 ). Slope values (k inact ) remained unchanged between CCL2-treated (4.81 Ϯ 0.08 mV) and control (4.72 Ϯ 0.15 mV) neurons. Moreover, lower concentration of CCL2 (10 nM) caused a left shift in the activation (V 1/2act ϭ Ϫ13.72 Ϯ 0.22 mV; n ϭ 4; *p Ͻ 0.05) and steady-state inactivation (V 1/2inact ϭ Ϫ37.02 Ϯ 0.16 mV; n ϭ 7; **p Ͻ 0.01) curves of Na v 1.8 (Fig. 3C,D ; Table 1 ). Figure 2 . Isolation of TTX-resistant Na v 1.8 currents in small-sized rat sensory neurons. Whole-cell voltage-clamp current traces of Na v 1.8 in small-diameter sensory neurons recorded following a 30 min incubation with 100 nM CCL2 in the absence (n ϭ 11) or presence of INCB3344 (100 nM; n ϭ 7), PTX (250 ng/ml; n ϭ 9), or gallein (20 M; n ϭ 6). Representative I-V curves of currents are determined using the pulse protocol indicated in the inset. Figure 3 . Na v 1.8 currents are increased in small sensory neurons following exposure to CCL2. A, Current-voltage relationships of Na v 1.8 were determined before (black circles) and after application of 10 nM (gray squares) or 100 nM (gray triangles) of CCL2. B, Peak Na v 1.8 current densities were significantly enhanced in the presence of 10 and 100 nM CCL2 (*p Ͻ 0.05 and ***p Ͻ 0.001, respectively, vs control; Student's t test; n ϭ 6 -13). Error bars indicate SEM. C, D, CCL2 shifted the activation (C) and steady-state inactivation (D) curves in a hyperpolarizing direction. The midpoint values of the activation (V 1/2act ) and inactivation (V 1/2inact ) curves are illustrated in Table 1 .
Potentiation of Na v 1.8 currents by CCL2 is blocked by the selective CCR2 antagonist We then investigated whether these changes in the biophysical properties of Na v 1.8 currents induced by CCL2 application were directly mediated by CCR2. For this purpose, electrophysiological recordings were performed on small sensory neurons following 30 min preincubation with 100 nM CCL2, in the presence of increasing concentrations of the CCR2 antagonist INCB3344 (ranging from 1 to 100 nM). As shown in Figure 2 , the increase in CCL2-induced Na v 1.8 sodium currents was considerably reduced in the presence of 100 nM INCB3344, thus demonstrating that the effects of CCL2 were CCR2 dependent. I-V curves of Na v 1.8 currents also revealed that coincubation with INCB3344 produced a concentration-dependent inhibition of the mean peak current density, with an IC 50 of 21 nM (Fig. 4 A, B) . At the highest concentration tested (100 nM), the selective CCR2 antagonist decreased by 85% the peak amplitude of Na v 1.8 current evoked by CCL2 (Ϫ99.13 Ϯ 2.77 pA/pF, n ϭ 11, for CCL2, vs Ϫ59.77 Ϯ 4.65 pA/pF, n ϭ 7, for CCL2 plus INCB3344;
### p Ͻ 0.001; Fig. 4 A, B) . No significant change in Na v 1.8 current density or kinetics was seen when INCB3344 (100 nM) was applied alone (Fig. 4 B) .
The changes in the activation and steady-state inactivation curves of Na v 1.8 observed under CCL2 stimulation (100 nM) were also prevented by the presence of INCB3344. Indeed, INCB3344 at 100 nM fully blocked the left shift in the activation curves of Na v 1.8 induced by CCL2 (Ϫ18.74 Ϯ 0.31 mV, n ϭ 11, for CCL2, vs Ϫ7.47 Ϯ 0.26 mV, n ϭ 7, for CCL2 plus INCB3344) ( ## p Ͻ 0.01; Fig. 4C , Table 1 ). In addition, the hyperpolarizing shift in the inactivation curve of TTX-R Na v 1.8 currents observed in response to CCL2 returned to baseline values following coincubation with the CCR2 antagonist. The half-inactivation potential was Ϫ40.61 Ϯ 0.09 mV using CCL2 alone (n ϭ 10), and Ϫ31.02 Ϯ 0.16 mV when incubating with 100 nM INCB3344 ( ### p Ͻ 0.001; n ϭ 5) (Fig. 4D, Table 1 ). The slope factors, k act and k inact were unaltered by the presence of INCB3344 (Table 1) .
G i/o -proteins participate in
CCL2-induced Na v 1.8 current activation CCR2 activation by CCL2 initiates intracellular signaling cascades among the ones coupling to heterotrimeric G-proteins of the G i family (Bajetto et al., 2002; Gosselin et al., 2008) . Before determining the possible role of G i/o -proteins in the CCL2 activation of Na v 1.8 current, we have first examined whether CCL2 activated CCR2 through a G i/o -coupled mode of action to decrease neuronal cAMP production and whether treatment with the irreversible inhibitor of G i/o -proteins, PTX (250 ng/ ml) inhibited the functional coupling of CCR2 to adenylyl cyclase. As shown in Figure 5A , CCL2 applied at a concentration of 100 nM to dissociated primary sensory neurons significantly decreased basal levels of cAMP up to 30% (*p Ͻ 0.05). Moreover, overnight pretreatment with PTX reversed by 70% the CCL2-induced inhibition of adenylyl cyclase activity ( # p Ͻ 0.05), thus demonstrating that CCR2 activation modulates the neuronal cAMP levels in a G i/o -proteindependent manner.
We next determined whether PTX treatment of acutely dissociated sensory neurons affected CCL2-induced Na v 1.8 current activation. Our results revealed that overnight incubation with ### p Ͻ 0.001, # p Ͻ 0.05, INCB3344 plus CCL2 vs CCL2 alone; Student's t test; n ϭ 6 -11; pound signs correspond to the values in the Table 1 ). Error bars indicate SEM. C, D, INCB3344 also significantly inhibits the leftward shift of the activation (C) ( ## p Ͻ 0.01) and inactivation (D) ( ### p Ͻ 0.001 compared with CCL2 alone) curves of Na v 1.8 current observed in the presence of 100 nM CCL2. The experimental conditions corresponding to control and 100 nM CCL2 have already been presented in Figure 3 . Half-activation and half-inactivation potentials and slope factors are summarized in Table 1 . PTX significantly prevented the Na v 1.8 current amplitude change induced by 100 nM CCL2, indicating that the influence of CCL2 on Na v 1.8 is dependent of the trimeric G i -protein complex (Fig. 2) . The peak current densities were Ϫ99.13 Ϯ 2.77 pA/pF (n ϭ 11) and Ϫ52.37 Ϯ 3.09 pA/pF (n ϭ 9) before and after application of PTX, respectively ( ### p Ͻ 0.001; Fig.  5 B, C) . Applied alone, PTX caused no significant changes in the Na v 1.8 current amplitude (Fig. 5C ). In addition, the hyperpolarized shift in the midpoint of activation, observed upon CCL2 stimulation (V 1/2act ϭ Ϫ18.74 Ϯ 0.31 mV; n ϭ 11) was completely inhibited in the presence of PTX (V 1/2act ϭ Ϫ7.04 Ϯ 0.22 mV; n ϭ 9) ( ## p Ͻ 0.01; Fig. 5D , Table 1 ). The k act value was not changed by PTX treatment (Table 1) .
CCL2 activates Na v 1.8 currents through the release of G␤␥ dimers
There is ample evidence in the literature demonstrating that G-protein ␤␥ subunits released from some GPCR upon receptor activation regulate a variety of downstream pathways to control various physiological functions . As a classical GPCR, CCR2 has also been shown to modulate different signaling pathways through the release of G␤␥ (Bajetto et al., 2002) . Therefore, we next determined the potential role of G␤␥ in CCL2-mediated Na v 1.8 activation. Dissociated primary sensory neurons were thus incubated overnight with 20 M gallein, a specific G␤␥ dimer signaling inhibitor Irannejad and Wedegaertner, 2010; Ukhanov et al., 2011) . As shown in Figure 2 , the increase in CCL2-induced Na v 1.8 sodium currents was blocked by gallein pretreatment. Under CCL2 stimulation, the peak current densities were Ϫ99.13 Ϯ 2.77 pA/pF (n ϭ 11) and Ϫ50.63 Ϯ 1.73 pA/pF (n ϭ 6) before and after application of gallein, respectively ( ### p Ͻ 0.001; Fig. 6 A, B) . Inhibition of G␤␥ also completely prevented the leftward shift in the activation curves of Na v 1.8 induced by CCL2 (Ϫ18.74 Ϯ 0.31 mV, n ϭ 11, for CCL2, vs Ϫ6.09 Ϯ 0.22 mV, n ϭ 6, for CCL2 plus gallein) ( ### p Ͻ 0.001; Fig. 6C , Table 1 ). The Na v 1.8 current amplitude was not changed following application of gallein alone (Fig. 6 B) .
Regulation of Na v 1.8 currents by CCL2 in medium-sized primary sensory neurons As shown in Figure 1 , G-I, Na v 1.8 channels are also expressed by medium-sized primary sensory neurons. We thus evaluated whether the biophysical properties of Na v 1.8 current were differently affected in medium-diameter primary sensory neurons compared with small sensory neurons. Whole-cell patch-clamp recordings demonstrated that CCL2 significantly increased TTXresistant Na v 1.8 current densities in dissociated medium DRG neurons of naive rats (Fig. 7) . The mean current amplitude at 0 mV was significantly higher after 100 nM CCL2 application (Ϫ82.60 Ϯ 4.24 pA/pF; n ϭ 11) compared with untreated DRG neurons (Ϫ62.19 Ϯ 1.55 pA/pF; n ϭ 18) ( Fig. 8 ; ***p Ͻ 0.001). Peak current densities were also significantly reduced following exposure to INCB3344 (Ϫ64.38 Ϯ 3.03 pA/pF; n ϭ 7; ### p Ͻ 0.001), PTX (Ϫ62.23 Ϯ 7.62 pA/pF; n ϭ 5; # p Ͻ 0.05), or gallein (Ϫ62.60 Ϯ 1.43 pA/pF; n ϭ 11; ### p Ͻ 0.001) (Figs. 7, 8 ). Unlike small-sized neurons, there was, however, no change in the activation and steady-state inactivation curves of Na v 1.8 following CCL2 treatment (Fig. 8C, Table 2 ).
Discussion
Reports on the CCL2/CCR2 chemokine/receptor complex in a number of chronic pain disorders led us to investigate the peripheral mechanisms of CCL2-induced pain facilitation (Rostène et al., 2007; White et al., 2009) . Using whole-cell patch-clamp recordings, we demonstrated here that CCL2 enhanced Na v 1.8 current densities in both small-and medium-sized acutely dissociated sensory neurons. We also found that CCL2 increased excitability in small sensory neurons by shifting the activation and steady-state inactivation curves of Na v 1.8 in the hyperpolarizing direction. This increase in Na v 1.8 current was blocked by the selective CCR2 antagonist. This confirms that CCR2 is directly involved in CCL2-induced changes in Na v 1.8 activity. We also found that the G␤␥ released from PTX-sensitive G i/o proteins is primarily responsible for the activation of Na v 1.8 currents in response to CCL2 in primary sensory neurons.
Neuromodulation of Na v 1.8 sodium channels by CCL2 Sustained pain hypersensitivity and neuronal hyperexcitability associated with nerve injury or disease-induced inflammatory responses of the peripheral nervous system are believed to result from chronic changes within DRG. In particular, modulation of voltage-gated sodium channels may underlie the increased excit- ability of primary afferent neurons (Dib-Hajj et al., 2009b; Docherty and Farmer, 2009; Swanwick et al., 2010) . Among them, Na v 1.8 has emerged as a key contributor to action potential generation in nociceptors (Cummins et al., 2007; Dib-Hajj et al., 2009a) . In support, functional knockdown of Na v 1.8 in rats or deletion of the Na v 1.8 gene reduces hyperalgesia and allodynia in neuropathic pain models (Dib-Hajj et al., 2010; Lampert et al., 2010) . Likewise, systemic and spinal administrations of Na v 1.8 channel blockers partially reverse pain-related behaviors in preclinical animal models of chronic pain (Bear et al., 2009; Bhattacharya et al., 2009; Matulenko et al., 2009; Priest, 2009 ). Although Na v 1.8 antagonists may have analgesic efficacy in patients coping with chronic pain, the high degree of structural homology within the VGSC family and side effects of existing blockers have limited their clinical use (England, 2008; Dworkin et al., 2010) . Given the fact that it is actually difficult to selectively target Na v 1.8, alternatives have been proposed like the indirect regulation of Na v 1.8 function by acting upstream via GPCR inhibition. In that respect, inflammatory mediators, such as prostaglandin, adenosine, and serotonin have been shown to influence both activity and trafficking of TTX-R sodium channels (Gold et al., 1996; Rush and Waxman, 2004; Liu et al., 2010; Ebersberger et al., 2011) .
Considerable data support the hypothesis that proinflammatory chemokines induce pain hypersensitivity, notably by causing sensory neuron hyperactivity (Wang et al., 2008; Miller et al., 2009; White et al., 2009) . Accordingly, the intraganglionic release of CCL2 strongly excites CCR2-expressing nociceptive DRG neurons (Oh et al., 2001; White et al., 2005; Sun et al., 2006; Jung et al., 2008) . The depolarization of these sensory neurons thus implies that a number of ion channels may be downstream targets of CCR2 activation. Here, we therefore investigated whether the chemokine CCL2 contributed to nociceptive neurons excitability through the enhancement of Na v 1.8 currents. We first observed by dual immunofluorescence staining that, in both acutely dissociated cells and DRG sections, CCR2 receptors were present in most small-to medium-sized sensory neurons, previously described to express Na v 1.8 (Lai et al., 2004; Devor, 2006; Cummins et al., 2007; Dib-Hajj et al., 2009a) . Consistently, we demonstrated using whole-cell patch-clamp recordings that acute application of CCL2 to small DRG neurons concentration-dependently increased the magnitude of Na v 1.8 currents and triggered a hyperpolarizing shift of both activation and inactivation curves. Interestingly, patch-clamp recordings from medium-sized DRG neurons revealed that CCL2 also enhanced the peak current amplitude of Na v 1.8 but was, however, inefficient in shifting the conductance-voltage and the steadystate inactivation curves to more hyperpolarized potentials. Thus, these results reveal that CCL2 affects the functional properties of Na v 1.8 in a cell type-specific manner within peripheral sensory ganglia.
Transactivation of Na v 1.8 is not the only CCL2-mediated mechanism that is likely to be important in the excitation of sensory neurons. Indeed, TRP cation channels, TRPV1 and TRPA1, participate in CCL2-induced nociceptor sensitization (Jung et al., 2008) . Similarly, inhibition of voltage-dependent K ϩ conductance has been hypothesized to arise from the action of CCL2 within DRG (Sun et al., 2006) . In addition to sensory neuron modulation, CCL2 spinally released may also contribute to the maintenance of central sensitization by potentiating the activity of NMDA and AMPA receptors or by causing GABAergic disinhibition (Gosselin et al., 2005; Gao et al., 2009) . The data reported here argue that Na v 1.8 channels are targets of CCL2-induced signaling pathway and that the mechanisms by which CCL2 enhances neuronal excitability depend on the subset of DRG neurons.
Functional significance of CCR2 receptor activation to the modulation of Na v 1.8 channel To date, several lines of evidence support a critical role of CCL2/ CCR2 in promoting behavioral changes associated with chronic pain White and Miller, 2010) . In particular, the recent progress in identifying CCR2 antagonists has revealed their effectiveness in reversing the nociceptive behaviors induced by focal nerve demyelination injury or HIV sensory neuropathy (Bhangoo et al., 2007 Jung et al., 2009) . Accordingly, we recently demonstrated that the selective CCR2 antagonist INCB3344 prevented the pronociceptive action of exogenous intraspinal CCL2 and attenuated tactile allodynia in nerve-injured rats Van Steenwinckel et al., 2011) . Here, we therefore evaluated whether treatment of small-and mediumsized sensory neurons with INCB3344 abolished CCL2-induced Na v 1.8 current activation. Our results demonstrated that application of INCB3344 concentration-dependently blocks CCL2-induced changes in Na v 1.8 current density or kinetics. Supporting the behavioral observations, these data clearly indicate that CCL2-induced pain facilitation is mediated by direct activation of CCR2 and that ### p Ͻ 0.001 gallein plus CCL2 compared with CCL2 alone; Student's t test; n ϭ 6 -11). Error bars indicate SEM. C, Gallein also completely reverses the leftward shift of activation curve of Na v 1.8 observed in the presence of 100 nM CCL2 ( ### p Ͻ 0.001). Note that the experimental conditions corresponding to control and 100 nM CCL2 have been shown previously in previous figures. Half-activation and half-inactivation potentials and slope factors are summarized in Table 1. CCR2 antagonists represent potential new pain-relieving drugs (Struthers and Pasternak, 2010) .
Downstream CCR2 signaling in sensory neurons
Different underlying mechanisms have been proposed to explain how inflammatory mediators acting via GPCR increased Na v 1.8 currents and nociceptor excitability (Priest, 2009; Lampert et al., 2010) . In particular, the Na v 1.8 channel was described as a final common target for several second-messenger cascades, including PKA, PKC, and p38 MAPK (Dib-Hajj et al., 2009b . As a classical GPCR, CCR2 is functionally coupled to G␣ and G␤␥ subunits of trimeric G-proteins and activates multiple signal transduction pathways, such as phospholipase C, ERK1/2, and p38 MAPK (Bajetto et al., 2002; Gosselin et al., 2008) . Here, we thus investigated the mechanisms that governed the increase of Na v 1.8 activity following CCL2 treatment. Our data strongly suggest Representative families of Na v 1.8 sodium currents in medium-sized sensory neurons. Average I-V curve family of currents recorded from medium neurons under CCL2 stimulation alone (100 nM; n ϭ 11), and in the presence of INCB3344 (100 nM; n ϭ 7), PTX (250 ng/ml; n ϭ 5), or gallein (20 M; n ϭ 11). INCB3344, PTX, and gallein all efficiently reverse CCL2-induced enhancement of Na v 1.8 currents.
Figure 8. Density and kinetic properties of Na v 1.8 currents in medium-sized sensory neurons. A, B, CCL2 increases the maximal peak current amplitude of Na v 1.8 (***p Ͻ 0.001, CCL2 alone vs control). The activation of Na v 1.8 currents induced by CCL2 is inhibited after treatment with INCB3344 ( ### p Ͻ 0.001 compared with CCL2 alone; Student's t test). C, No change in the steady-state inactivation curve of Na v 1.8 was seen following CCL2 treatment (n ϭ 6 -11). D, E, Both PTX and gallein reverse CCL2-induced Na v 1.8 current activation ( # p Ͻ 0.05 and ### p Ͻ 0.001 compared with CCL2 alone, respectively). Half-maximal potentials (V 1/2 ) and slope (k) values are reported in Table 2 . Error bars indicate SEM.
that CCL2/CCR2 enhances Na v 1.8 currents in a G i/o -proteindependent manner in both small-and medium-sized DRG neurons. Specifically, we showed that preventing G i/o recruitment by PTX treatment completely reversed CCL2-induced inhibition of neuronal cAMP production, potentiation of Na v 1.8 current density, as well as the shifts in activation and inactivation kinetics. The full inhibition of Na v 1.8 currents by PTX further excludes the involvement of additional G-proteins in the modulation of Na v 1.8 by CCL2. Since PTX inhibits the dissociation of G␤␥ from G␣i␤␥ complex , we next examined the participation of G␤␥ downstream signaling to CCL2-related Na v 1.8 activation. Our results demonstrated that the specific G␤␥ dimer inhibitor gallein fully blocked the activation of Na v 1.8 currents in response to CCL2 in both populations of sensory neurons. Consequently, these findings suggest that the classical cAMP/PKA signaling pathway resulting from the activation of PTX-sensitive G ␣i proteins is not involved in the regulation of Na v 1.8 by CCL2.
Interestingly, we also found that CCL2 differently influenced the biophysical properties of Na v 1.8 in DRG neuron subpopulations. In small sensory neurons, CCL2 increased Na v 1.8 current amplitude, which was associated with hyperpolarizing shifts in voltage dependence of both activation and inactivation curves. In contrast, treatment of medium-sized DRG cells with CCL2 only affected the Na v 1.8 current density without altering the gating properties of the channel. The different actions of CCL2 may thus reflect the implication of distinct signaling pathways. Based on previous findings (Gold et al., 1998; Vijayaragavan et al., 2004) , we might speculate that, in small sensory neurons, CCL2 increases Na v 1.8 current density and produces changes in voltage dependence of activation and inactivation via PKC phosphorylation of serine residues within the I-II loop of the Na v 1.8 ␣ subunit. Above all, we might propose that the stimulation of PLC␤ via the release of G␤␥-dimers mediates the activation of PKC, a PKC isoform shown to potentiate Na v 1.8 current (Smrcka, 2008; Cang et al., 2009 ). In contrast, we might hypothesize that CCL2 regulates Na v 1.8 function in medium-sized DRG neurons via a p38 MAPK-dependent pathway (Jin and Gereau, 2006; Hudmon et al., 2008) , the activities of p38 MAPK being stimulated by mechanisms that involve dissociation of ␤␥ subunits (Goldsmith and Dhanasekaran, 2007) . Alternatively, as for N-type Ca 2ϩ channels and inwardly rectifying K ϩ channels (Smrcka, 2008) , direct binding of free G␤␥ subunits to the C-terminal domain of sodium channel may induce persistent Na ϩ currents in neurons (Ma et al., 1997; Mantegazza et al., 2005) .
Given the important role played by CCL2 in neuronal-glial interactions and in the temporal onset of pathological pain, we identified here a new mechanism by which CCL2 probably promotes peripheral sensitization and pain hypersensitivity. Since hyperexcitability and spontaneous action potential firing mediated by Na v 1.8 in sensory neurons are thought to be the source of some types of chronic pain states, inhibition of CCL2/CCR2 signaling represents a promising avenue for therapeutic intervention.
